INS and metabolic disease: Faecalibacterium is often reduced in individuals with metabolic disorders, including obesity, insulin resistance, and type 2 diabetes mellitus, and several studies have reported negative correlations between Faecalibacterium abundance and fasting glucose and/or insulin levels [38,39,40].